[ Tue, Mar 14th 2023 ]: WOPRAI
Meyer Shields Maintained (AXS) at Hold with Increased Target to $64 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Brian Abrahams Reiterated (BCRX) at Hold and Held Target at $10 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Kristen Owen Maintained (BHIL) at Buy with Decreased Target to $175 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Adam Samuelson Maintained (BHIL) at Hold with Decreased Target to $131 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Benjamin Theurer Maintained (BHIL) at Buy with Decreased Target to $105 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Anna Glaessgen Initiated (ASO) at Strong Buy and Held Target at $73 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Itay Michaeli Maintained (AXL) at Hold with Decreased Target to $9 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jake Civiello Initiated (CBU) at Strong Buy and Held Target at $66 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Benjamin Burnett Initiated (ACLX) at Strong Buy and Held Target at $43 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Tazeen Ahmad Maintained (ACAD) at Hold and Held Target at $23 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jeffrey Hung Maintained (ACAD) at Hold with Increased Target to $20 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Gregory Renza Reiterated (ACAD) at Buy and Held Target at $27 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Sumant Kulkarni Maintained (ACAD) at Strong Buy with Increased Target to $26 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Charles Duncan Maintained (ACAD) at Buy with Increased Target to $33 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Neena Bitritto-Garg Maintained (ACAD) at Hold with Increased Target to $21 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Andrew Fein Maintained (ACAD) at Strong Buy with Increased Target to $28 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Bernie McTernan Reiterated (ABNB) at Strong Buy and Held Target at $155 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Nicholas Jones Reiterated (BKNG) at Buy on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Katja Jancic Maintained (AA) at Hold and Held Target at $50 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Yi Chen Reiterated (ZYXI) at Strong Buy with Decreased Target to $20 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Omar Nokta Reiterated (ZIM) at Hold and Held Target at $20 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jeffrey Silber Maintained (VRSK) at Hold and Held Target at $188 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Gregory Renza Reiterated (VIRX) at Buy and Held Target at $8 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Robert Burns Reiterated (VIRX) at Strong Buy and Held Target at $35 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Joseph Feldman Maintained (WSM) at Buy with Decreased Target to $71 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jon Arfstrom Maintained (WTFC) at Buy with Decreased Target to $95 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jake Bartlett Maintained (WEN) at Strong Buy with Increased Target to $28 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Timur Braziler Maintained (WAL) at Buy with Decreased Target to $65 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Joseph Pantginis Reiterated (VYNE) at Strong Buy with Increased Target to $28 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Itay Michaeli Maintained (VC) at Hold with Increased Target to $165 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Eric Ross Reiterated (VCSA) at Buy and Held Target at $60 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Arun Jayaram Upgraded (VET) to Buy on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Pete Stavropoulos Maintained (ANNX) at Buy with Decreased Target to $18 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Chris Shibutani Maintained (AMLX) at Hold with Increased Target to $47 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Itay Michaeli Maintained (AMLX) at Strong Buy with Increased Target to $54 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $50 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Nicholas Jones Reiterated (SOND) at Buy and Held Target at $55 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jade Rahmani Maintained (STWD) at Buy with Decreased Target to $22 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Jacob Johnson Reiterated (CDMO) at Buy and Held Target at $22 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Sean Dodge Reiterated (CDMO) at Buy and Held Target at $20 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Paul Knight Upgraded (CDMO) to Buy and Held Target at $20 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Bill Sutherland Reiterated (AMED) at Strong Buy and Held Target at $115 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Scott Fidel Reiterated (AMED) at Hold and Held Target at $103 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Joseph Quatrochi Maintained (AMAT) at Buy and Held Target at $135 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Sheila Kahyaoglu Maintained (TDG) at Strong Buy and Held Target at $850 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Heiko Ihle Reiterated (TRX) at Strong Buy and Held Target at $1.1 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Sean Kim Initiated (TRVI) at Strong Buy and Held Target at $7 on, Mar 14th, 2023
[ Tue, Mar 14th 2023 ]: WOPRAI
Chris Pierce Upgraded (TRUE) to Strong Buy and Held Target at $3.5 on, Mar 14th, 2023
Bill Sutherland Reiterated (AMED) at Strong Buy and Held Target at $115 on, Mar 14th, 2023
Bill Sutherland of Benchmark, Reiterated "Amedisys, Inc." (AMED) at Strong Buy and Held Target at $115 on, Mar 14th, 2023.
Bill has made no other calls on AMED in the last 4 months.
There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 2 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Steve Valiquette of "Barclays" Initiated at Hold and Held Target at $93 on, Monday, March 13th, 2023
- Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
These are the ratings of the 4 analyists that currently disagree with Bill
- Jonathan Yong of "Credit Suisse" Reiterated at Buy and Held Target at $115 on, Monday, February 27th, 2023
- Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $111 on, Tuesday, February 21st, 2023
- Mark Miller of "Benchmark" Maintained at Strong Buy with Decreased Target to $115 on, Thursday, February 16th, 2023
- Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023